Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2
Ludivine Grzelak(The University of Melbourne), Samira Fafi‐Kremer(Centre National de la Recherche Scientifique), Aurélie Velay(Hôpitaux Universitaires de Strasbourg), Timothée Bruel(Institut Pasteur), Cyril Planchais(Institut Pasteur), Nathalie Reix, Catherine Schmidt‐Mutter(Inserm), Isabelle Staropoli(Centre National de la Recherche Scientifique), Yves Hansmann(Hôpitaux Universitaires de Strasbourg), Arnaud Fontanet(Institut Pasteur), Olivier Schwartz(Centre National de la Recherche Scientifique), Yoann Madec(Institut Pasteur), Hugo Mouquet(Institut Pasteur), Ludovic Glady, Maria Gonzalez, David Rey, Nicolás Meyer, de Sèze(Hôpital d'Hautepierre), Marie-Josée Wendling(Institut de Virologie), Floriane Gallais(Inserm)
Cited by 85
Related Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|706
Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
|Archives of Neurology|2008|612